Weiss Asset Management LP[1 »

Apellis Pharmaceuticals shares owned by Weiss Asset Management LP[1

Quarter-by-quarter ownership of Apellis Pharmaceuticals (APLS) shares owned by Weiss Asset Management LP[1 from 13F filings

Historical chart of Weiss Asset Management LP[1 investment in Apellis Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Apellis Pharmaceuticals held by Weiss Asset Management LP[1 consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Apellis Pharmaceuticals by Weiss Asset Management LP[1

Quarter filed Position value Share count Share price at filing
2023-12-31 $639k 11k 59.86

More positions owned by Weiss Asset Management LP[1

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Splunk Note 1.125% 9/1 (Principal)
Theravance Biopharma (TBPH)
Cytokinetics Note 3.500% 7/0 (Principal)
Tesla Motors Call Option (TSLA)
American Airls Put Option (AAL)
Nextera Energy (NEE)
Vnet Group Note 2/0 (Principal)
Atmus Filtration Technologies Ord (ATMU)
Li Auto Note 0.250% 5/0 (Principal)
Bridgebio Pharma Note 2.250% 2/0 (Principal)
Ares Capital Corp Note 4.625% 3/0 (Principal)
CRH Ord Put Option (CRH)
Coinbase Global Com Cl A Put Option (COIN)
NiSource (NI)

View all positions for Weiss Asset Management LP[1

Top funds holding Apellis Pharmaceuticals

Wellington Management Company
EcoR1 Capital
venBio Select Advisor
Vanguard Group
Jennison Associates
Octagon Capital Advisors
Jpmorgan Chase & Co
T. Rowe Price Associates
Assenagon Asset Management
Logos Global Management
Boxer Capital
Artal Group
Citadel Advisors
Caption Management
Norges Bank Investment Management

View all funds holding Apellis Pharmaceuticals